WeVote

Bill

Bill

HB 5149

Establishing the West Virginia Prescription Drug Affordability Board

2026 Regular Session Introduced by Kayla Young

West Virginia would create a Prescription Drug Affordability Board to review and regulate pharmaceutical pricing to improve medication cost accessibility for residents.

To House Health and Human Resources
0
WeVote Research Nonpartisan
Bill Summary · HB 5149

Legislative bill overview

HB 5149 would establish a Prescription Drug Affordability Board in West Virginia with authority to review, analyze, and potentially regulate drug pricing within the state. The board would have powers to negotiate prices, monitor pharmaceutical costs, and implement measures to improve medication affordability for residents.

Why is this important

Prescription drug costs are a significant burden for West Virginia residents, particularly in rural areas with limited healthcare access. Creating a state-level board could provide a mechanism to address high drug prices that disproportionately affect seniors and uninsured populations, though implementation costs and effectiveness remain uncertain.

Potential points of contention

  • Federal authority conflicts: Pharmaceutical regulation is primarily a federal function; unclear whether a state board has legal authority to regulate drug pricing or negotiate with manufacturers operating nationally
  • Manufacturer response: Pharmaceutical companies may challenge the board's authority in court or adjust pricing/distribution strategies in response, potentially affecting drug availability
  • Implementation costs and funding: Establishing and operating an oversight board requires state resources; bill unclear on budget allocation and how the board would be funded
  • Scope of authority: Details on what enforcement powers the board would have and how it would interact with existing insurance regulations need clarification

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.